Severe and fatal allergic reactions to food in children are rareMarch 21, 2002Fears that the rates of severe or fatal allergic reactions to food are increasing dramatically are unfounded, finds a national, 10 year, study in the Archives of Disease in Childhood. Such reactions are rare in the UK, but children who have asthma are at greater risk, the findings show. The research team examined national death statistics for children up to the age of 15 years from 1990 to 1998. They also analysed monthly reports generated by the British Paediatric Surveillance System (BPSU) from 1998 to 2000. This collects data from all UK consultant paediatricians, almost 95 per cent of whom participate. The data showed that over the past 10 years eight children died from an allergic reaction to food. Milk was responsible for four of the deaths. No child under 13 died from peanut allergy. One child with a mixed food allergic reaction died from an overdose of epinephrine, which is used to treat it. As the UK population of children up to the age of 16 is 13 million, that gives a rate of 0.006 deaths for every 100,000 children, say the authors. Between 1998 and 2000 there were six near deaths, none of which was caused by peanut, and 49 severe reactions, 10 of which were. Mixed food and cashew nuts accounted for 16. This gives a rate of 0.2 near deaths and 0.19 severe reactions for every 100,000 children. Coexisting asthma featured in three of the deaths, five of the near deaths, and over half of the severe reactions. The authors calculate that if 5 per cent of the population of children in the UK has a food allergy, the risk of that child dying from his or her allergy would be 1 in 800,000 a year. They conclude: “The finding of so few deaths in such a large population should reassure parents and doctors that the risk of death is small.” This is particularly important for children under the age of 10, they say, in whom the risk was even smaller, and many of whom grow out of their allergic responses. Nevertheless, a second study warns that schools are poorly informed about nut allergy or what to do in the event of a severe allergic reaction in a pupil. A survey of 83 randomly selected schools in South West England, showed that 54 per cent (45) had at least one child who was known to be allergic. But only a third of the children had access to treatment at school. Around a third of schools with an allergic child were unable to name the signs of either a mild or severe allergic reaction to nuts. More than four out of 10 either had no staff suitably trained in the use of appropriate treatment, or did not respond to the question. Less than half of these schools gave information about nut allergy to dinner supervisors. British Medical Journal (BMJ) |
|||||||||||||||||||||
| Related Asthma Current Events and Asthma News Articles Ancestry attracts, but love is blind People preferentially marry those with similar ancestry, but their decisions are not necessarily based on hair, eye or skin colour. Common plastics chemicals linked to ADHD symptoms Phthalates are important components of many consumer products, including toys, cleaning materials, plastics, and personal care items. Asthma a significant risk factor for complications in children with H1N1 A new study on pediatric H1N1 influenza admissions has found that asthma is a significant risk factor for severe disease in children with pandemic H1N1 compared with the seasonal flu. Mother's Depression a Risk Factor in Childhood Asthma Symptoms, Study Suggests Asthma symptoms can worsen in children with depressed mothers, according to research from Johns Hopkins Children's Center published online in the Journal of Pediatric Psychology. Sweet -- sugared polymer a new weapon against allergies and asthma Scientists at Johns Hopkins and their colleagues have developed sugar-coated polymer strands that selectively kill off cells involved in triggering aggressive allergy and asthma attacks. Pivotal study for PSD502 -- the first potential treatment for premature ejaculation At the annual meeting of the Sexual Medicine Society of North America (SMSNA), Inc. in San Diego, Sciele Pharma, Inc., a Shionogi Company and Plethora Solutions Limited, a wholly owned subsidiary of Plethora Solutions Holdings PLC ("Plethora" - AIM:PLE)., today presented data from its second positive pivotal study of PSD502 for the treatment of premature ejaculation (PE). Aileron collaborates study in Nature: Stapled peptides inhibit Notch1 transcription factor This research validates the potential for Stapled Peptides to modulate key intracellular biological targets, such as transcription factors, that have not been addressable with current small molecule or biologic drug modalities. Women with asthma feel worse Women with asthma are more anxious, find it harder to sleep and are more tired during the day than their male counterparts, but nevertheless tend to be better at following their treatment. Poll: Many parents, high-priority adults who tried to get H1N1 vaccine unable to get it A new national poll from Harvard School of Public Health (HSPH) researchers found that a majority of adults who tried to get the H1N1 vaccine for themselves or their children have been unable to do so. Key player identified in cascade that leads to hypertension-related kidney damage A key player in a cascade that likely begins with stress and leads to high blood pressure and kidney damage has been identified by researchers who say the finding may lead to better ways to control both. More Asthma Current Events and Asthma News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||